Baseline vitamin D status is associated with glycemic and weight loss outcomes in patients with type 2 diabetes treated with semaglutide
ObjectiveSemaglutide, a glucagon-like peptide-1 receptor agonist, is an established therapy for type 2 diabetes (T2D), offering robust glycemic control and weight reduction. Vitamin D has been implicated in metabolic regulation, yet its influence on semaglutide-induced outcomes remains unclear.Resea...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2026-04-01
|
| 叢編: | Frontiers in Nutrition |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fnut.2026.1833045/full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|